Support
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.

SELECTED REFERENCES

Published articles using tissue microarrays from US Biomax:

  1. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Lili C. Kudo1, Liubov Parfenova, Nancy Vi, Kimbley Lau, Justine Pomakian, Paul Valdmanis, Guy A. Rouleau, Harry V. Vinters, Martina Wiedau-Pazos1 and Stanislav L. Karsten. Human Molecular Genetics. 2010 10:1093. (Product used TMA ). (link)
  2. The tissue microarray OWL schema: An open-source tool for sharing tissue microarray data. Hyunseok P Kang, Charles D Borromeo, Jules J Berman and Michael J Becich. ORIGINAL ARTICLE. 2010 1(1):9. (Product used TMA ). (link)
  3. Fluorescence in situ hybridization analysis with a tissue microarray: ‘FISH and chips’ analysis of pathology archives. Haruhiko Sugimura1, Hiroki Mori, Kiyoko Nagura, Shin-ichiro Kiyose, Tao Hong, Masaru Isozaki, Hisaki Igarashi, Kazuya Shinmura, Akio Hasegawa, Yasuhiko Kitayama and Fumihiko Tanioka. Pathology International. 2010 60(8):543-550. (Product used TMA ). (link)
  4. Increased Inhibitor of Differentiation 4 (Id4) Expression in Glioblastoma: A Tissue Microarray Study . Weifin Zeng, Elisabeth J. Rushing, Daniel P. Hartmann and Norio Azumi. J Cancer. 2010 1(1):5. (Product used TMA ). (link)
  5. Tissue microarray construction from gross specimens: development of a novel simple technique. Santosh Kumar Sharma, Lopamudra Deka, Ruchika Gupta, Shilpa Gupta, Deepak Kumar Singh and Sompal Singh. J Clin Pathol . 2010 10:1136. (Product used TMA ). (link)
  6. Fluorescence in situ hybridization analysis with a tissue microarray:'FISH and chips' analysis of pathology archivespin. Haruhiko Sugimura, Hiroki Mori, Kiyoko Nagura, Shin-ichiro Kiyose, Tao Hong, Masaru Isozaki, Hisaki Igarashi, Kazuya Shinmura, Akio Hasegawa, Yasuhiko Kitayama and Fumihiko Tanioka. Pathology International. 2010 60:543-550. (Product used TMA ). (link)
  7. A Tissue Microarray Study of Osteosarcoma: Histopathologic and Immunohistochemical Validation of Xenotransplanted Tumors as Preclinical Models. Mayordomo E, Machado I, Giner F, Kresse SH, Myklebost O, Carda C, Navarro S, Llombart-Bosch A. Appl Immunohistochem Mol Morphol. 2010 :. (Product used TMA ). (link)
  8. Tissue microarray study of lung squamous cell carcinoma Expression of high mobility group protein A1 . Huang Wei HE RAN Peng Qin-Chang Ting Yang . Clinical Papers . 2010 :. (Product used TMA ). (link)
  9. Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development. . Verified by National Institutes of Health Clinical Center . 2010 :. (Product used TMA ). (link)
  10. Examination of oral cancer biomarkers by tissue microarray analysis. Choi, Peter and Jordan, C Diana and Mendez, Eduardo and Houck, John and Yueh, Bevan and Farwell, D Gregory and Futran, Neal and Chen. Archives of otolaryngology--head & neck surgery. 2010 134(5):539-546. (Product used TMA ). (link)
  11. Tissue-microarray based immunohistochemical analysis of survival pathways in nodular sclerosing classical Hodgkin lymphoma as compared with Non-Hodgkin’s ymphoma. Jitakshi De, Robert E. Brown. Int J Clin Exp Med. 2010 3(1):55-68. (Product used TMA ). (link)
  12. Tissue microarray analysis to evaluate the role of heat shock protein 27 as a potential biomarker in pancreatic cancer.. E. Gallmeier, D. Bader, H. Seeliger, G. Assmann, D. Buchner, E. de Toni, T. Kirchner, C. J. Bruns, B. Goke and C. Schafer . Journal of Clinical Oncology. 2010 28:. (Product used TMA ). (link)
  13. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.. Kudo LC, Parfenova L, Vi N, Lau K, Pomakian J, Valdmanis P, Rouleau GA, Vinters HV, Wiedau-Pazos M and Karsten SL. Hum Mol Genet. 2010 19(16):3233-53. (Product used TMA ). (link)
  14. Trefoil Factor 3 Immunohistochemical Characterization of Follicular Thyroid Lesions From Tissue Microarray. Mihir R. Patel, MD; Paul C. Bryson, MD; Carol G. Shores, MD, PhD; Craig F. Hart, MD;Leigh B. Thorne, MD; Allison M. Deal, MS; Adam M. Zanation, MD. . 2010 :. (Product used TMA ). (link)
  15. The tumor suppressor gene KCTD11REN is regulated by Sp1 and methylation and its expression is reduced in tumors. M Michela Mancarelli, Francesca Zazzeroni, Lucia Ciccocioppo, Daria Capece, Agnese Po, Simona Murgo, Raffaello Di Camillo, Christian Rinaldi, Elisabetta Ferretti, Alberto Gulino and Edoardo Alesse. Molecular Cancer. 2010 9:172. (Product used TMA ). (link)
  16. Tissue Microarray Applications in Drug Discovery for Pancreatic Cancer . . Drug Discovery in Pancreatic Cancer . 2010 10:205-222. (Product used TMA ). (link)
  17. Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast. Y Lin1, J Hatem, J Wang, A Quinn, DG Hicks, P Tang. Biotechnic & Histochemistry. 2010 10:3109. (Product used TMA ). (link)
  18. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. Ruo-Kai Lin, Yi-Shuan Hsieh, Pinpin Lin, Han-Shui Hsu, Chih-Yi Chen, Yen-An Tang, Chung-Fan Lee and Yi-Ching Wang. J Clin Invest. 2010 120(2):521-532. (Product used TMA ). (link)
  19. Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma. Stefanie Meyer, Thomas Vogt, Michael Landthaler, Anna Berand, Albrecht Reichle, Frauke Bataille, Andreas H. Marx, Anne Menz, Arndt Hartmann, Leoni A. Kunz-Schughart and Peter J. Wild. PPAR Research. 2010 2010:11. (Product used TMA ). (link)
  20. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. M E Kupferman, T Jiffar, A El-Naggar, T Yilmaz, G Zhou, T Xie, L Feng, J Wang, F C Holsinger, D Yu and J N Myers . Oncogene . 2010 29:2047-2059 . (Product used TMA ). (link)
  21. Neurofilament Heavy Polypeptide Regulates the Akt Catenin Pathway in Human Esophageal Squamous Cell Carcinoma. Myoung Sook Kim, Xiaofei Chang, Cynthia LeBron, Jatin K. Nagpal, Juna Lee, Yiping Huang, Keishi Yamashita, Barry Trink, Edward A. Ratovitski and David Sidransky. PLoS One. 2010 10:1371. (Product used TMA ). (link)
  22. Growth and Invasion of Sporadic Colorectal Adenocarcinomas in Terms of Genetic Change. Seon Ae Roh, Eun Young Choi, Dong Hyung Cho, Se Jin Jang, Seon Young Kim, Yong Sung Kim and Jin Cheon Kim. J Korean Med Sci. 2010 25(3):353-360 . (Product used TMA ). (link)
  23. Prognostic significance of apoptotic cell death in bladder cancer: a tissue microarray study on 179 urothelial carcinomas from cystectomy specimens. Eva Karamitopoulou, Cyrill A. Rentsch, Regula Markwalder, Claudio Vallan, George N. Thalmann and Thomas Brunner. Pathology. 2010 42(1) :37-42 . (Product used TMA ). (link)
  24. Molecular prognosticators of complex karyotype soft tissue sarcoma outcome: a tissue microarray-based study. G. Lahat1, D. Tuvin1, C. Wei, W. L. Wang, R. E. Pollock, D. A. Anaya, B. N. Bekele, L. Corely, A. J. Lazar, P. W. Pisters1 and D. Lev. Oxford Journals Medicine Annals of Oncology . 2010 21(5):1112-1120. (Product used TMA ). (link)
  25. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. . . The American journal of surgical pathology. 2010 34(10):1532-0979. (Product used TMA ). (link)
  26. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Dahinden, C; Ingold, B; Wild, P; Boysen, G; Luu, V D; Montani, M; Kristiansen, G; Sulser, T; Bühlmann, P; Moch, H; Schraml, P (2010). Clinical Cancer Research. 2010 16(1):88-98. (Product used TMA ). (link)
  27. Tissue Microarray for Routine Clinical Breast Biomarker Analysis The British Columbia Cancer Agency 2008 Experience. Thomas A. Thomson, MD, Chen Zhou, MD, PhD, Kathy Ceballos, MD and Bryan Knight, MBChB, MMed (Anat Path), PhD . American Journal of Clinical Pathology. 2010 133:909-914 . (Product used TMA ). (link)
  28. Assessing the Application of Tissue Microarray Technology to Kidney Research . Ming-Zhi Zhang, Yinghao Su, Bing Yao, Wei Zheng, Mark deCaestecker and Raymond C. Harris . Journal of Histochemistry and Cytochemistry. 2010 10:1369. (Product used TMA ). (link)
  29. A Tissue Microarray Study of Osteosarcoma: Histopathologic and Immunohistochemical Validation of Xenotransplanted Tumors as Preclinical Models. Mayordomo, Empar MD; Machado, Isidro MD; Giner, Francisco MD; Kresse, Stine H. PhD; Myklebost, Ola PhD; Carda, Carmen MD; Navarro, Samuel MD; Llombart-Bosch and Antonio MD. Applied Immunohistochemistry & Molecular Morphology. 2010 10:1097. (Product used TMA ). (link)
  30. Use of Tissue Microarray to Facilitate Oncology Research. Panagiotis Gouveris, Paul M. Weinberger and Amanda Psyrri . . 2010 10:(1007/978). (Product used TMA ). (link)
  31. Molecular analysis of oral squamous cell carcinoma: A tissue microarray study. MC Solomon, S Carnelio and V Gudattu. ORIGINAL ARTICLE. 2010 47(2):166-172. (Product used TMA ). (link)
  32. Multi-Layered Tissue Array for Microfluidic, High-Throughput Screening of Barrier Tissue. . Johns Hopkins University . 2010 :. (Product used TMA ). (link)
  33. Credentialing Preclinical Pediatric Xenograft Models Using Gene Expression and Tissue Microarray Analysis . Craig C. Whiteford, Sven Bilke, Braden T. Greer, Qingrong Chen, Till A. Braunschweig, Nicola Cenacchi, Jun S. Wei, Malcolm A. Smith, Peter Houghton, Christopher Morton, C. Patrick Reynolds, Richard Lock, Richard Gorlick, Chand Khanna, Carol J. Thiele, Mikiko Takikita, Daniel Catchpoole1, Stephen M. Hewitt and Javed Khan. Cancer Research . 2010 10:1158. (Product used TMA ). (link)
  34. Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients. Clin Cancer Res January. Clin Cancer Res. 2010 16:651-663. (Product used TMA ). (link)
  35. Tissue microarray and immunohistochemistry as tools for evaluation of antibodies against Chlamydia-like bacteria. . Borel, Nicole Casson, Nicola Entenza, Jose M Kaiser, Carmen Pospischil, Andreas Greub, Gilbert . Journal of medical microbiology. 2009 :. (Product used TMA ). (link)
  36. Tissue microarray: A high-throughput immunohistochemical tool. Benjamin Yang. . 2009 :. (Product used TMA ). (link)
  37. Tissue Microarray : A rapidly evolving diagnostic and research tool.. Nazar M.T. Jawhar. Department of Pathology. 2009 29(2):123-127. (Product used TMA ). (link)
  38. Sex differences in emphysema and airway disease in smokers. Pat G Camp, Harvey O Coxson, Robert D Levy, Sreekumar G Pillai, Wayne Anderson, J-rgen Vestbo, Susan M Kennedy, Edwin K Silverman, David A Lomas and Peter D Pare. Chest. 2009 136(6):1480-8. (Product used TMA ). (link)
  39. Proteomic and Tissue Array Profiling Identifies Elevated Hypoxia-Regulated Proteins in Pancreatic Ductal Adenocarcinoma . Yazhou Cui a, Denglu Zhang a, Qing Jia b, Tianliang Li a, Weidong Zhang b and Jinxiang Han a. Cancer Investigation. 2009 27(7):747-755 . (Product used TMA ). (link)
  40. High-throughput Immunophenotyping of 43 Ferret Lymphomas Using Tissue Microarray Technology. A. S. Hammer, B. Williams, H. H. Dietz and S. J. Hamilton-Dutoit. Previous | Next Article. 2009 44(2):196-203 . (Product used TMA ). (link)
  41. Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. Heather E Kleiner, Prasad Krishnan, Jesse Tubbs, Mark Smith, Carol Meschonat, Runhua Shi, Mary Lowery-Nordberg, Patrick Adegboyega, Marcia Unger, James Cardelli, Quyen Chu, J Michael Mathis, John Clifford, Arrigo De Benedetti and Benjamin DL Li. J Exp Clin Cancer Res. 2009 28(1):54. (Product used TMA ). (link)
  42. Tissue Section BioChain-Genomic DNA, cDNA, RNA, Protein, Antibody. Mary Ellen Maddalena,Jaclyn Fox,Jianqing Chen,Weiwei Feng,Aldo Cagnolini,Karen E.Linder,Michael F.Tweedle,Adrian D.Nunn and Laura E. Lantry. J. Nucl. Med. 2009 8::282 - 291. (Product used TMA ). (link)
  43. Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small-Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis in Human Melanoma CellsPlk1 in Melanoma. Travis L Schmit, Weixiong Zhong, Vijayasaradhi Setaluri, Vladimir S Spiegelman and Nihal Ahmad. Journal of Investigative Dermatology. 2009 129:2843-2853 . (Product used TMA ). (link)
  44. Loss of Antigenicity in Stored Sections of Breast Cancer Tissue Microarrays. Jennifer H. Fergenbaum,Montserrat Garcia-Closas,Stephen M. Hewitt,Jolanta Lissowska3,Lori CSakoda1 and Mark E.Sherman1. Cancer Epidemiology, Biomarkers & Prevention. 2009 13:667. (Product used TMA ). (link)
  45. Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers. R Modali1, J Goedert, Engels, LW Ayers and K Bhatia. Infectious Agents and Cancer. 2009 4:1. (Product used TMA ). (link)
  46. Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. Mee-Kyung Cha, Kyung-Hoon Suh and Il-Han Kim . Journal of Experimental & Clinical Cancer Research. 2009 28:93. (Product used TMA ). (link)
  47. Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma. P M Lindholm1, Y Soini, M Myll-rniemi, S Knuutila, M Heikinheimo, V L Kinnula1 and K Salmenkivi. J Clin Pathol. 2009 62:339-344 . (Product used TMA ). (link)
  48. Postmortem Brain Tissue for Drug Discovery in Psychiatric Research. . Schizophrenia Bulletin. 2009 35(6):1031-1033. (Product used TMA ). (link)
  49. Expression of the AQP-1 water channel in normal human tissues:a semiquantitative study using tissue microarray technology. A. Mobasheri and D. Marples. Am J Physiol Cell Physiol. 2009 286:529-537. (Product used TMA ). (link)
  50. The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways. . Blood. 2009 8:1585-1595. (Product used TMA ). (link)
  51. Estrogen and Progesterone Receptor Expression is not Always Specific for Mammary and Gynecologic Carcinomas: A Tissue Microarray and Pooled Literature Review Study. Wei, Shi MD, PhD, Said-Al-Naief, Nasser DDS, MS, Hameed and Omar MBChB. Applied Immunohistochemistry & Molecular Morphology. 2009 17(5): 393-402. (Product used TMA ). (link)
  52. Barbara Riegel,DNSc,RN,CS,FAAN Debra K.Moser,DNSc,RN,FAAN. . Journal of Cardiovascular Nursing. 2009 0889-4655 :1550-5049 . (Product used TMA ). (link)
  53. MET/PKC expression correlate with metastasis and inhibition is synergistic in lung cancer. Leonardo Faoro1, Gustavo M Cervantes, Benjamin D Ferguson, Tanguy Y Seiwert, Soheil Yala, Wicki T Vigneswaran, Maria Westerhoff, Maria S Tretiakova, Mark K Ferguson, Glaci L Moura, Aliya N Husain, Everett E Vokes1 and Ravi Salgia1. J Carcinog. 2009 8:15. (Product used TMA ). (link)
  54. Merkel Cell Carcinoma: Recent Progress and Current Priorities on Etiology, Pathogenesis and Clinical Management. . Journal of Clinical Oncology. 2009 27(24) :4021-4026. (Product used TMA ). (link)
  55. Tissue Engineering Part B: Reviews Considerations for Tissue-Engineered and Regenerative Medicine Product Development Prior to Clinical Trials in the United States. Mark H.Lee, Judith A.Arcidiacono, Anastacia M. Bilek, Jeremiah J. Wille, Caitilin A. Hamill, Keith M. Wonnacott, Martha A.Wells and Steven S.Oh. To cite this article.. 2009 10:1089. (Product used TMA ). (link)
  56. BMP-2 signaling in ovarian cancer and its association with poor prognosis. Cecile Le Page,Marie-Line Puiffe,Liliane Meunier,Magdalena Zietarska,Manon de Ladurantaye,Patricia N Tonin,Diane Provencher and Anne-Marie Mes-Masson. Journal of Ovarian Research . 2009 2:4. (Product used TMA ). (link)
  57. The Internally Truncated LRP5 Receptor Presents a Therapeutic Target in Breast Cancer. Peyman Bjorklund, Jessica Svedlund,Anna-Karin Olsson, Goran kerstrom and Gunnar Westin. . 2009 :. (Product used TMA ). (link)
  58. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoCRegulation of cell migration by MyoGEF. D Wu, M Asiedu and Q Wei. Oncogene . 2009 28:2219-2230 . (Product used TMA ). (link)
  59. The Guanine Nucleotide Exchange Factor SWAP-70 Modulates the Migration and Invasiveness of Human Malignant Glioma Cells1,2 . Ho Jun Seol, Christian A Smith, Bodour Salhia and James T Rutka. Transl Oncol. 2009 2(4):300-309. (Product used TMA ). (link)
  60. Liquid Tissue(R) Patent Licensed For Amyloidosis Proteomic Assay . . ROCKVILLE, Md. 2009 :. (Product used TMA ). (link)
  61. ACOMPARISON OF IMAGINGMODALITIES TOMONITOR THERMAL ANDMECHANICAL ULTRASOUND TISSUE THERAPIES. Arthur Worthington, Sankar Narasimhan, Jahan Tavakkoli and Michael C.Kolios. . 2009 37(2):170. (Product used TMA ). (link)
  62. An Analysis of Trends and Growth Factor Receptor Expression of GI Carcinoid Tumors. Kanika A. Bowen, Scott R. Silva, Jessica N. Johnson, Hung Q. Doan, Lindsey N. Jackson, Pat Gulhati, Suimin Qiu, Taylor S. Riall1 and B. Mark Evers. Journal of Gastrointestinal Surgery. 2009 :. (Product used TMA ). (link)
  63. Translational bioinformatics applications in genome medicine Atul J Butte. . Genome Medicine. 2009 1:64. (Product used TMA PA2081). (link)
  64. Type I Insulin-like Growth Factor Receptor Induces Pulmonary Tumorigenesis1. . Neoplasia. 2009 11(7):672-682. (Product used TMA LC1921). (link)
  65. Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation. Bin Zheng, Joseph H. Jeong, John M. Asara, Yuan-Ying Yuan, Scott R. Granter, Lynda Chin, Lewis C. Cantley. Molecular cell. 2009 33:237-247. (Product used TMA ). (link)
  66. The Guanine Nucleotide Exchange Factor SWAP-70 Modulates the Migration and Invasiveness of Human Malignant Glioma Cells1,2. Ho Jun Seol, Christian A. Smith, BodourSalhia and James T.Rutka. Translational Oncology. 2009 2(4):300-309. (Product used TMA GL803). (link)
  67. Aberrant Prothymosin-alpha Expression in Human Bladder Cancer . Y. Tsai, Y. Jou,G . Lee, Y. Chen, A. Shiau, H. Tsai, C.Wu, and T. Tzai. Urology. 2009 73(1):188-192. (Product used TMA BL241,BL801). (link)
  68. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC. D Wu, M Asiedu & Q Wei . Oncogene. 2009 10:1038. (Product used TMA ). (link)
  69. Aberrant Promoter Methylation of Sparc in Ovarian Cancer1,2 . Matthew J Socha, Neveen Said, Yanshan Dai, Joseph Kwong, Preetha Ramalingam, Vuong Trieu, Neil Desai, Samuel C Mok and Kouros Motamed. Neoplasia. 2009 11(2):126-135. (Product used TMA OV801,OV2001). (link)
  70. Kr|[uuml]|ppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. H-Q Zheng, Z Zhou, J Huang, L Chaudhury and J-T Dong C Chen . Oncogene. 2009 28:3702-3713 . (Product used TMA ). (link)
  71. The a-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells. MR Russell, WL Jamieson, NG Dolloff and A Fatatis. Oncogene. 2009 28: 412-421. (Product used TMA ). (link)
  72. Promoter DNA Methylation of Oncostatin M receptor as a Novel Diagnostic and Therapeutic Marker in Colon Cancer. Myoung Sook Kim, Joost Louwagie, Beatriz Carvalho, Jochim S. Terhaar sive Droste, Hannah Lui Park1, Young Kwang Chae, Keishi Yamashita, Junwei Liu, Kimberly Laskie Ostrow, Shizhang Ling, Rafael Guerrero-Preston, Semra Demokan, Zubeyde Yalniz, Nejat Dalay, Gerrit A. Meijer, Wim Van Criekinge and David Sidransky . . 2009 :. (Product used TMA ). (link)
  73. Effects of milk replacer formulation on measures of mammary growth and composition in Holstein heifers. K. M. Daniels, A. V.Capuco,M. L, McGilliard, R. E.James and R. M.Akers. J.Dairy Sci.. 2009 92:5937-5950. (Product used TMA ). (link)
  74. Proinflammatory Effect of TWEAK/Fn14 Interaction in Human Retinal Pigment Epithelial Cells. Nobuyuki Ebihara, Masafumi Nakayama, Tomoko Tokura, Minoru Iwatsu, Hiroko Ushio and Akira Murakami. Current Eye Research. 2009 34(10):836-844 . (Product used TMA ). (link)
  75. iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype. Loos, Sbastien Bougnaud, Oleg Klychnikov, Ka Wan Li, Thang V.Pham, Jian Wang, Hrvoje Miletic, Zhao Peng, Rolf Bjerkvig Connie R. Jimenez and Simone P. Niclou. Molecular & Cellular Proteomics . 2009 8:2595-2612. (Product used TMA ). (link)
  76. Immunoreactivity of icam-1 in human tumors, metastases and normal tissues. Hayes SH and Seigel GM. Int J Clin Exp Pathol . 2009 2(6):553-60. (Product used TMA ). (link)
  77. The mRNA Binding Proteins HuR and Tristetraprolin Regulate Cyclooxygenase 2 Expression During Colon Carcinogenesis. L. Young, S. Sanduja, K. Bemis Standoli, E. Pena, R. Price and D.Dixon. Gastroenterology. 2009 5:1669-1679. (Product used TMA CO801). (link)
  78. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism . Christian F Singer, Anneliese Fink-Retter, Daphne Gschwantler-Kaulich, Theresia Thalhammer, Gernot Hudelist, Ruth Mueller, Klaus Czerwenka and Ernst Kubista. Endocrine-Related Cancer . 2009 13 (4) :1101 -1107 . (Product used TMA ). (link)
  79. Pancreas-specific protein disulfide isomerase has a cell type-specific expression in various mouse tissues and is absent in human pancreatic adenocarcinoma cells: implications for its functions . Xin-Miao Fu1, Xiangchen Dai1, Jian Ding1 and Bao Ting Zhu1. Journal of Molecular Histology. 2009 :189-199. (Product used TMA ). (link)
  80. JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma. Qingshan Chang, Jianguo Chen, Kevin J Beezhold, Vince Castranova, Xianglin Shi1 and Fei Chen. Molecular Cancer. 2009 8:64. (Product used TMA ). (link)
  81. Roles of estrogen receptor and in modulating urothelial cell proliferation. Jian Teng, Zun-Yi Wang, David F Jarrard and Dale E Bjorling. Endocrine-Related Cancer. 2009 15 (1) :351 -364. (Product used TMA ). (link)
  82. Original Article Immunoreactivity of ICAM-1 in Human Tumors, Metastases and Normal Tissues. Sarah H. Hayes and Gail M. Seigel. Int J Clin Exp Pathol. 2009 2: 553-560. (Product used TMA ). (link)
  83. Cancer Cell Biology Tumor suppressor function of Rab25 in triple negative breast cancer . Ji-Ming Cheng, Lisa Volk, Deepak Kumar Mummidavarapu Janaki, Sudhir Vyakaranam, Sophia Ran and Krishna A. Rao. International Journal of Cancer. 2009 9999:999A. (Product used TMA ). (link)
  84. Kv1.3 voltage-gated K+ channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. Soo Hwa Jang, Kyung-Sun Kang,Pan Dong Ryu and So Yeong Lee. BMB. 2009 42(8) :535-539. (Product used TMA ). (link)
  85. Aberrant Promoter Methylation of Sparc in Ovarian Cancer1,2. Matthew J. Socha, Neveen Said, Yanshan Dai, Joseph Kwong, Preetha Ramalingam, Vuong Trieu, Neil Desai, Samuel C. Mok and Kouros Motamed. Neoplasia. 2009 11(2):126-135. (Product used TMA ). (link)
  86. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells. Heather C Workman1, Jamie K Miller, Ellen Q Ingalla, Rouminder P Kaur, Diane I Yamamoto, Laurel A Beckett, Lawrence JT Young,Robert D Cardiff, Alexander D Borowsky, Kermit L arraway, Colleen Sweeney and Kermit L Carraway III. Breast Cancer Research. 2009 11:70. (Product used TMA ). (link)
  87. Enhancement of lung carcinogenesis initiated with 4-(N-hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone by Ogg1 gene deficiency in female, but not male, mice. Maki Igarashi, Manabu Watanabe, Midori Yoshida, Kouichi Sugaya, Yoshifumi Endo, Nozomi Miyajima, Masayoshi Abe, Sumio Sugano and Dai Nakae. The Journal of Toxicological Sciences. 2009 34:163-174. (Product used TMA ). (link)
  88. Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients. Bih-Rong Wei, Shelley B. Hoover, Mark M. Ross, Weidong Zhou, Francesco Meani, Jennifer B. Edwards, Elizabeth I. Spehalski1a, John I. Risinger, W. Gregory Alvord, Octavio A. Quiones, Claudio Belluco, Luca Martella, Elio Campagnutta, Antonella Ravaggi, Ren-Ming Dai1c, Paul K. Goldsmith, Kevin D. Woolard, Sergio Pecorelli, Lance A. Liotta, Emanuel F. Petricoin and R. Mark Simpson. plosone. 2009 :. (Product used TMA ). (link)
  89. Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells. Koji Kawaguchi, Hideki Murakami, Tetsuo Taniguchi, Makiko Fujii, Shigehisa Kawata, Takayuki Fukui ,Yutaka Kondo ,Hirotaka Osada ,Noriyasu Usami ,Kohei Yokoi ,Yuichi Ueda ,Yasushi Yatabe ,Masafumi Ito ,Yoshitsugu Horio, Toyoaki Hida and Yoshitaka Sekido. Carcinogenesis. 2009 30(7):1097-1105. (Product used TMA ). (link)
  90. In Vivo Expansion of the Mammary Stem/ Progenitor Cell Population by Xanthosine Infusion. Anthony V. Capuco, Christina M. Evock-Clover, Andrea Minuti and David L. Wood. Experimental Biology and Medicine. 2009 234:475-482 . (Product used TMA ). (link)
  91. Deregulation of IKBKE Is Associated with Tumor Progression, Poor Prognosis, and Cisplatin Resistance in Ovarian Cancer. Jian-Ping Guo, Shao-Kun Shu, Lili He, Yi-Chun Lee, Patricia A. Kruk,Seija Grenman, Santo V. Nicosia, Gil Mor, Michael J. Schell||, Domenico Coppola and Jin Q.Cheng . American Journal of Pathology. 2009 175:324-333. (Product used TMA ). (link)
  92. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Bin Li, Sai Wah Tsao, Yuk Yin Li, Xianghong Wang, Ming Tat Ling, Yong Chuan Wong, Qing Yu He and Annie L M Cheung . International Journal of Cancer. 2009 9999:. (Product used TMA ES802). (link)
  93. Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody. Cameron,Michael J. BSc, Rubin, Mark A. MD,Chang,Martin C.MD,PhD,Aster Jon C. MD, PhD, Haack, Herbert PhD, Johnson, Laura A.BSc, Fry, ChristopherJ. PhD Crosby, Katherine BSc,Polakiewicz, Roberto D. PhD, Stelow, Edward B. MD, Hong, Seung-Mo MD, PhD, French, Christopher A. MD,Schwartz and Brian E.PhD. . The American Journal of Surgical. 2009 33:984. (Product used TMA CO701). (link)
  94. A Regulatory Mechanism for RSK2 NH2-Terminal Kinase Activity. Yong-Yeon Cho, Ke Yao, Angelo Pugliese, Margarita L. Malakhova, Ann M. Bode and Zigang Dong . Cancer Research. 2009 69(10):4398-4406. (Product used TMA SK801). (link)
  95. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug. Julie Guillermet-Guibert, Lise Davenne, Dimitri Pchejetski, Nathalie Saint-Laurent, Leyre Brizuela, C-line Guilbeau-Frugier, Marie-Bernadette Delisle, Olivier Cuvillier, Christiane Susini and Corinne Bousquet. Mol Cancer Ther . 2009 8:809. (Product used TMA ). (link)
  96. Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells. Anuraag Shrivastav, Shailly Varma, Arnie Senger, Ramji L Khandelwal, Svein Carlsen and Rajendra K Sharma . The Journal of Pathology. 2009 :. (Product used TMA BR802). (link)
  97. Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer. Takeo Fujita, Hirokuni Ikeda, Naruto Taira, Shinji Hatoh, Minoru Naito and Hiroyoshi Doihara. BMC Cancer . 2009 9:87. (Product used TMA ). (link)
  98. Overexpression and Mislocalization of the Chromosomal Segregation Protein Separase in Multiple Human Cancers. Rene Meyer, Viacheslav Fofanov, AnilK.Panigrahi, Fatima Merchant, Nenggang Zhang and Debananda Pati . Clinical Cancer Research. 2009 15:2703. (Product used TMA BS26011). (link)
  99. Novel Breast Cancer Metastasis-Associated Proteins. Jiapei Ho, Jacklyn-Wai-Fun Kong, Lee-Yee Choong, Marie-Chiew-Shia Loh, Weiyi Toy, Poh-Kuan Chong, Chee-Hong Wong, Chow-Yin Wong, Nilesh Shah and Yoon-Pin Lim. J.Proteome Res.. 2009 8 (2):583-594. (Product used TMA ). (link)
  100. Fibroblast Growth Factor Receptor 1 ansformed Mammary Epithelial Cells Are Dependent on RSK Activity for Growth and Survival. Wa Xian, Leontios Pappas, Darshan Pandya, Laura M. Selfors, Patrick W. Derksen, Michiel de Bruin,Nathanael S. Gray, Jos Jonkers, Jeffrey M. Rosen and Joan S. Brugge. Cancer Research. 2009 69:2244. (Product used TMA BR805 BR809). (link)
  101. Role of CCL11/eotaxin-1 signaling in ovarian cancer. Vera Levina, Brian M. Nolen, Adele M. Marrangoni, Peng Cheng, Jeffrey R. Marks, Miroslaw J. Szczepanski, Marta E. Szajnik, Elieser Gorelik and Anna E. Lokshin. Clin Cancer Res.. 2009 15:2647-2656. (Product used TMA ). (link)
  102. Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression. Adam S. Feldman, Jacqueline Banyard, Chin-Lee Wu, W. Scott McDougal and Bruce R. Zetter. Clinical Cancer Research. 2009 15:1024. (Product used TMA BL801). (link)
  103. IL15 Can Reverse the Unresponsiveness of Wilms'Tumor Antigen-Specific CTL in Patients with Prostate Cancer. Judy W. King, Sharyn Thomas, Fabrizio Corsi, Liquan Gao, Roberto Dina Roopinder Gillmore, Katharine Pigott, Amir Kaisary, Hans J. Stauss and Jonathan Waxman. Clinical Cancer Research. 2009 15:1145. (Product used TMA ). (link)
  104. AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001. Marin Marinov, Algirdas Ziogas, Olivier. Pardo, Liwen Terence Tan, Tony Dhillon, Francesco A. Mauri, Heidi A. Lane,Nicholas R. Lemoine, Uwe Zangemeister-Wittke, Michael J.Seckl and Alexandre Arcaro. Clinical Cancer Research. 2009 15:1277. (Product used TMA BN04011 BS04111). (link)
  105. Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness. Chaoyang Jin, Yu-an Yang, Miriam R. Anver, Nicole Morris, Xiangchun Wang and Ying E. Zhang. Cancer Research. 2009 69:735. (Product used TMA BR801). (link)
  106. Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis. Ann M. Bode, Yong-Yeon Cho, Duo Zheng, Feng Zhu, Marna E. Ericson, Wei-Ya Ma, Ke Yao and Zigang Dong. Cancer Research. 2009 69:905. (Product used TMA ). (link)
  107. Aberrant Promoter Methylation of Sparc in Ovarian Cancer. Matthew J. Socha, Neveen Said, Yanshan Dai, Joseph Kwong,Preetha Ramalingam,Vuong Trieu, Neil Desai, Samuel C. Mok and Kouros Motamed. NEOplasia. 2009 11(2):126-135. (Product used TMA OV801 OV2001). (link)
  108. cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation. LINNERTH, N. M. GREENAWAY, J. B, PETRIK, J. MOOREHEAD, R. A.. International Journal of Gynecological Cancer. 2009 18(6):1248-1257. (Product used TMA ). (link)
  109. Aberrant Prothymosin-alpha Expression in Human Bladder Cancer. Yuh-Shyan Tsai, Yeong-Chin Jou, Gia-Fong Lee, Yeong-Chang Chen, Ai-Li Shiau, Hsin-Tzu Tsai, Chao-Liang Wu and Tzong-Shin Tzai. Basic and Translational Science. 2009 73(1):189-192. (Product used TMA BL241 BL801). (link)
  110. A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene . Stephane Gobeil, Xiaochun Zhu, Charles J. Doillon and Michae R. Green. Cold Spring Harbor Laboratory Press . 2008 22:2932-2940 . (Product used TMA ). (link)
  111. SmgGDS Regulates Cell Proliferation, Migration and NF-B Transcriptional Activity in Non-small Cell Lung Carcinoma. Gaik Wei Tew1, Ellen L. Lorimer, Tracy J. Berg, Huiying Zhi, Rongshan Li and Carol L.Williams. The Journal of Biological Chemistry. 2008 283:963-976. (Product used TMA ). (link)
  112. Evaluation of CD133 expression in brain tumors using tissue array. Keiji Shimizu, Ayano Kumasawa, Shinichi Toyonaga, Takanori Masahira, Hiromochi Nakabayashi, Kaechang Park, Toshio Yawata Department Neurosurgery, Kochi Medical School and Kochi Japan. . 2008 :. (Product used TMA ). (link)
  113. SATB1 tethers multiple gene loci to reprogram expression profile driving breast cancer metastasis . Han,Hye-Jung, Kohwi, Yoshinori, Kohwi-Shigematsu and Terumi. Lawrence Berkeley National Laboratory. 2008 :. (Product used TMA ). (link)
  114. Genomic and Proteomic Profiles Reveal the Association of Gelsolin to TP Status and Bladder Cancer Progression. Marta Sanchez-Carbayo, Nicholas D. Socci and Lee Ric. american journal of pathology. 2008 28:12(22). (Product used TMA ). (link)
  115. Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors. . WORLD JOURNAL OF GASTROENTEROLOGY. 2008 14:47. (Product used TMA ). (link)
  116. Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization. Chih-Ping Han, Ming-Yung Lee, Shu-Ling Tzeng, Chung-Chin Yao, Po-Hui Wang, Ya-Wen Cheng, Show-Li Chen, Teresa S Wu, Yeu-Sheng Tyan and Lai-Fong Kok. J Exp Clin Cancer Res. 2008 27(1):25. (Product used TMA BCN962). (link)
  117. Transforming Growth Factor-（beta-1) Promotes Matrix Metalloproteinase-9-CMediated Oral Cancer Invasion through Snail Expression. Limin Sun, Michelle E. Diamond, Adam J. Ottaviano, Mathew J. Joseph, Vijayalakshmi Ananthanarayan and Hidayatullah G. Munshi. Mol Cancer Res. 2008 6:1. (Product used TMA ). (link)
  118. Regulatory effect of nerve growth factor in 9 integrin ependent progression of glioblastoma. Meghan C.Brown, Izabela Staniszewska, Philip Lazarovici, George P. Tuszynski, Luis Del Valle and Cezary Marcinkiewicz . Neuro Oncol . 2008 10(6):968-980. (Product used TMA ). (link)
  119. Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization. Chih-Ping Han, Ming-Yung Lee, Shu-Ling Tzeng, Chung-Chin Yao, Po-Hui Wang, Ya-Wen Cheng, Show-Li Chen, Teresa S Wu, Yeu-Sheng Tyan and Lai-Fong Kok. J Exp Clin Cancer Res. 2008 27(1):25. (Product used TMA BCN962). (link)
  120. Transforming Growth Factor-B1 Promotes Matrix Metalloproteinase-9 Mediated Oral Cancer Invasion through Snail Expression. Limin Sun, Michelle E. Diamond, Adam J. Ottaviano, Mathew J. Joseph, Vijayalakshmi Ananthanarayan Hidayatullah G.Munshi. Mol Cancer Res. 2008 6(1):. (Product used TMA ). (link)
  121. Feedback Regulation between Zipcode Binding Protein 1 and Catenin mRNAs in Breast Cancer Cells. Wei Gu, Amber L. Wells, Feng Pan and Robert H. Singer. Molecular and Cellular Biology. 2008 28(16):4963-4974. (Product used TMA ). (link)
  122. Sox7 Is an Independent Checkpoint for beta-Catenin Function in Prostate and Colon Epithelial Cells. Lizheng Guo, Diansheng Zhong, Stephen Lau, Xiuju Liu, Xue-Yuan Dong, Xiaodong Sun, Vincent W. Yang, Paula M. Vertino, Carlos S. Moreno, Vijay Varma, Jin-Tang Dong and Wei Zhou. Cancer Genes and Genomics. 2008 6:1421-1430. (Product used TMA ). (link)
  123. Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Chun-Liang Chen, Ling Cen, Jennifer Kohout, Brian Hutzen, Christina Chan, Fu-Chuan Hsieh, Abbey Loy, Victor Huang, Gong Cheng and Jiayuh Lin. Molecular Cancer. 2008 7:78-89. (Product used TMA ). (link)
  124. Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression. Nawfal I Ismail, Gurjeet Kaur, Hasnah Hashim Mohammed S Hassan. Cancer Cell Int. 2008 8:6. (Product used TMA BR1001, BR2001). (link)
  125. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer. Kiwon Lee, Yin Liu, Jun Qin Mo, Jinsong Zhang, Zhongyun Dong and Shan Lu. BMC Cancer. 2008 8:158. (Product used TMA ). (link)
  126. Identification of interleukin-13 receptor a2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. Bharat H. Joshi, Rada A. Puri, Pamela Leland, Frederick Varricchio, Ghanshyam Gupta, Mehmet Kocak, Richard J. Gilbertson Raj K. Puri,. Neuro-Oncology. 2008 10:265-274. (Product used TMA ). (link)
  127. Fluorophore-conjugated anti-CEA Antibody for the Intraoperative Imaging of Pancreatic and Colorectal Cancer. Sharmeela Kaushal, Michele K. McElroy, George A. Luiken, Mark A. Talamini, A. R. Moossa, Robert M. Hoffman and Michael Bouvet. Journal of Gastrointestinal Surgery. 2008 12:1938-1950. (Product used TMA ). (link)
  128. Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer. Takeo Fujita, Weijun Liu, Hiroyoshi Doihara, Hiroshi Date and Yong Wan. Clinical Cancer Research. 2008 14:1966-1975. (Product used TMA ). (link)
  129. ssDNA-Binding Protein 2 Is Frequently Hypermethylated and Suppresses Cell Growth in Human Prostate Cancer. Jun-Wei Liu, Jatin K.Nagpal, Wenyue Sun and Juna Lee. Clinical Cancer Research. 2008 14:3754-3760. (Product used TMA ). (link)
  130. Monoclonal Antibody CC188 Binds a Carbohydrate Epitope Expressed on the Surface of Both Colorectal Cancer Stem Cells and their Differentiated Progeny. Mai Xu, Yuan Yuan, Yang Xia and Samuel Achilefu. Clinical Cancer Research. 2008 14:7461-7469. (Product used TMA ). (link)
  131. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Jian Teng, Zun-Yi Wang, David F Jarrard and Dale E Bjorling. Endocr Relat Cancer. 2008 15:351-364. (Product used TMA BC19111, PR801). (link)
  132. A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene. Stephane Gobeil, Xiaochun Zhu, Charles J.Doillon Michael R.Green. Genes & Dev. 2008 22:2932-2940. (Product used TMA ME1001). (link)
  133. Identification of a Core Set of 58 Gene Transcripts With Broad and Specific Expression in the Microvasculature. Elisabet Wallgard, Erik Larsson, Liqun He, Mats Hellstrom, Annika Armulik, aya H. Nisancioglu, Guillem Genove, Per Lindahl, Christer Betsholtz . Arteriosclerosis,Thrombosis Vascular Biology. 2008 28:1469. (Product used TMA ). (link)
  134. CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism. Whitney L. Jamieson, Saori Shimizu, Julia A. D'Ambrosio1, Olimpia Meucci1 and Alessandro Fatatis. Cancer Research. 2008 68:1715-1722. (Product used TMA ). (link)
  135. Cyclin-Dependent Kinase 3-Mediated Activating Transcription Factor 1 Phosphorylation Enhances Cell Transformation. Duo Zheng, Yong-Yeon Cho, Andy T. Y. Lau, Jishuai Zhang, Wei-Ya Ma, Ann M.Bode and Zigang Dong . Cancer Research. 2008 68:7650-7660. (Product used TMA ). (link)
  136. Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Anindita Bhoumik, Boris Fichtman, Charles DeRossi, Wolfgang Breitwieser, Harriet M. Kluger, Sean Davis, Antonio Subtil, Paul Meltzer, Stan Krajewski and Nic Jones Ze'ev Ronai. PNAS. 2008 105:1674-1679 . (Product used TMA ). (link)
  137. Regulation of Skp2-p27 Axis by the Cdh1/Anaphase-Promoting Complex Pathway in Colorectal Tumorigenesis. Takeo Fujita, Weijun Liu, Hiroyoshi Doihara and Yong Wan. American Journal of Pathology. 2008 173:217-228. (Product used TMA ). (link)
  138. Regulatory effect of nerve growth factor in {alpha}9beta1 integrin-dependent progression of glioblastoma. Meghan C. Brown, Izabela Staniszewska, Philip Lazarovici, George P. Tuszynski, Luis Del Valle and Cezary Marcinkiewicz . Neuro Oncol. 2008 10(6):968-980. (Product used TMA ). (link)
  139. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression . Kristina E. Hoot, Jessyka Lighthall, Gangwen Han, Shi-Long Lu, Allen Li, Wenjun Ju, Molly Kulesz-Martin, Erwin Bottinger and Xiao-Jing Wang. J.Clin.Invest. 2008 118(8):2722-2732. (Product used TMA ). (link)
  140. Calcification of Multipotent Prostate Tumor Endothelium . Andrew C.Dudley, Zia A.Khan, Shou-Ching Shih, Soo-Young Kang, Bernadette M. M. Zwaans, Joyce Bischoff and Michael Klagsbrun. Cancer Cell. 2008 14(3):201-211. (Product used TMA ). (link)
  141. Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice. R. Wang, K. Sengupta, C. Li, H. Kim, L. Cao, C. Xiao, S.Kim, X.Xu, Y.Zheng and B.Chilton. Cancer Cell. 2008 14(4):312 - 323. (Product used TMA ). (link)
  142. The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development . Tyson V. Sharpa, Ahmad Al-Attarb, Daniel E. Foxlera, Li Dingc, Thomas Q. de A. Vallima, Yining Zhanga, Hala S. Nijmeha, Thomas M. Webba, Andrew G. Nicholsond, Qunyuan Zhange, Aldi Krajae, Ian Spendloveb, John Osbornec, Elaine Mardisc and Gregory D. Longmoref . PANS. 2008 15(50):9932-19937. (Product used ). (link)
  143. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Meissner, M. Whiteside, T. L. van Kuik-Romein, P. Valesky, E. M. van den Elsen, P. J. Kaufmann and R. Seliger. British Journal of Dermatology. 2008 158(5):930-940. (Product used TMA ). (link)
  144. Overexpression of the [alpha]v[beta]6 Integrin in Endometrial Cancer. Hecht Jonathan L. MD PhD, Dolinski Brian M., Gardner Humphrey A.MD, Violette Shelia M. PhD and Weinreb Paul H. PhD . Applied Immunohistochemistry & Molecular Morphology. 2008 16(6):543-547. (Product used TMA ). (link)
  145. Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: Expression in cancer tissue and adjacent non-cancerous tissue. Matthias Zitt, Gerold Untergasser and Albert Amberger. Disease Markers. 2008 24(2):101-109. (Product used TMA ). (link)
  146. Hedgehog Signaling Regulates Brain Tumor Initiating Cell Proliferation and Portends Shorter Survival for Patients with PTEN-Coexpressing Glioblastomas . Qijin Xu, Xiangpeng Yuan, Gentao Liu, Keith L. Black and John S Yu. Stem Cells. 2008 26(12):3018-3026. (Product used TMA ). (link)
  147. SmgGDS Regulates Cell Proliferation, Migration, and NF-kappa B Transcriptional Activity in Non-small Cell Lung Carcinoma. Gaik Wei Tew, Ellen L. Lorimer, Tracy J. Berg, Huiying Zhi, Rongshan Li and Carol L. Williams. J.Biol.Chem. 2008 283(2):963-976. (Product used TMA ). (link)
  148. Regulation of 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) by Src Involves Tyrosine Phosphorylation of PDK1 and Src Homology 2 Domain Binding. Keum-Jin Yang, Sanghee Shin, Longzhen Piao, Eulsoon Shin, Yuwen Li, Kyeong Ah Park, Hee Sun Byun, Minho Won, Janghee Hong, Gi Ryang Kweon, Gang Min Hur, Jeong Ho Seok, Taehoon Chun, Derek P. Brazil, Brian A. Hemmings and Jongsun Park. J. Biol. Chem. 2008 283(3):1480-1491. (Product used TMA ). (link)
  149. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism . Yong-Hun Lee, Allan R. Albig, MaryAnn Regner, Barbara J. Schiemann and William P. Schiemann . Carcinogenesis. 2008 29(12):2243-2251. (Product used TMA BR241). (link)
  150. In Virto and In Vivo Photosensitizing Applications of Photofrin in Malignant Melanoma Cells. Cheng-Jen Chang, Jau-Song Yu and Fu-Chan Wei. Chang Guang Med J. 2008 31(3):260-267. (Product used TMA ). (link)
  151. Immunohistochemical determination of the P15INK4b protein expression in cutaneous squamous cell carcinoma. Ahmed I. Moad, Tan Mei Lan, Gurjeet Kaur, Hasnah Hashim, Mohamed J. E. M. F. Mabruk . Journal of Cutaneous Pathology. 2008 36(2):183-189. (Product used TMA ). (link)
  152. Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression. Giolanta Kogianni, Marjorie M. Walker, Jonathan Waxman and Justin Sturge. European Journal of Cancer. 2008 45(4):685-693. (Product used TMA PR951 PR952). (link)
  153. Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. Skliris G P,Hube F,Gheorghiu I,Mutawe M M,Penner C,Watson P H,Murphy L C,Leygue E,and Myal Y. Histopathology. 2008 52(3):355-369. (Product used TMA ). (link)
  154. Expression and sub-cellular localization of the CCAAT/enhancer binding protein in relation to postnatal development and malignancy of the prostate. Juan Zhang, John Erby Wilkinson, Mesfin Gonit, Rick Keck, Steven Selman, Manohar Ratnam . The Prostate. 2008 68(11):1206-1214. (Product used TMA PR802 PR952 BC19111). (link)
  155. S100A4 overexpression proves to be independent marker for breast cancer progression. Nawfal I Ismail, Gurjeet Kaur, Hasnah Hashim and Mohammed S Hassan. Cancer Cell International. 2008 8(12):1475-2867. (Product used TMA BR2001). (link)
  156. BK Virus as a Cofactor in the Etiology of Prostate Cancer in Its Early Stages. Dweepanita Das, Kirk Wojno and Michael J. Imperiale. J of Virology. 2008 82(6):2705-2714. (Product used TMA ). (link)
  157. Current Topics in Human Genetics: Studies in Complex Diseases. Hong-Wen Deng, Hui Shen, Yong-Jun Liu. World Scientific. 2008 :475. (Product used ). (link)
  158. Decreased Plakophilin-1 Expression Promotes Increased Motility in Head and Neck Squamous Cell Carcinoma Cells. Tammy and James K. Wahl .ect. Cell Communication and Adhesion. 2007 2(3): 99-109. (Product used TMA ). (link)
  159. Expression of matrix metalloproteinases (MMP1, 2, 9, and 11) in metastatic lymph node tissue of breast cancer patients. . A. Fink-Retter, D. Gschwantler-Kaulich, G. Hudelist, I. Walter, K. Czerwenka and C.Singer . Journal of Clinical Oncology. 2007 1(25):. (Product used TMA ). (link)
  160. Increased Expression of the Collagen Internalization Receptor uPARAP/Endo180 in the Stroma of Head and Neck Cancer. Jay Sulek, Rebecca A. Wagenaar-Miller, Jessica Shireman, Alfredo Molinolo, Daniel H.Madsen, Lars H. Engelholm,Niels Behrendt and Thomas H.Bugge . Journal of Histochemistry and Cytochemistry. 2007 55 (4):347-353 . (Product used TMA ). (link)
  161. Mammaglobin vs GCDFP-15: An Immunohistologic Validation Survey: Materials and Methods. Rohit Bhargava, MD, Sushi Beriwal, MD and David J.Dabbs. American Journal of Clinical Pathology. 2007 127(1):103-113. (Product used TMA ). (link)
  162. A novel tissue array technique for high-throughput tissue microarray analysis microarray groups . Hui-Yong Jiang, Xue-Feng Zhang, Li Liu, Hui-Ling Li and Tong Zhao. In Vitro Cellular & Developmental Biology - Animal. 2007 43(3):109-112. (Product used TMA ). (link)
  163. BKV as a Cofactor in the Etiology of Prostate Cancer in its Early Stages. Dweepanita Das, Kirk Wojno and Michael J. Imperiale. J.Virol. 2007 :. (Product used TMA ). (link)
  164. A Suppressive Role of the Prolyl Isomerase Pin1 in Cellular Apoptosis Mediated by the Death-associated Protein Daxx . Akihide Ryo, Akiko Hirai, Mayuko Nishi, Yih-Cherng Liou, Kilian Perrem, Sheng-Cai Lin, Hisashi Hirano, Sam W.Lee and Ichiro Aoki. THE JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 282(50):36671-36681. (Product used TMA ). (link)
  165. Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. T Harada, C Chelala, V Bhakta, T Chaplin, K Caulee, P Baril, BD Young and NR Lemoine. Oncogene (online publication). 2007 1:1951–1960. (Product used TMA PA801). (link)
  166. Increased Expression of the Collagen Internalization Receptor uPARAP/Endo180 in the Stroma of Head and Neck Cancer. Jay Sulek, Rebecca A.,et all. J Histochem Cytochem. 2007 55:347-453. (Product used TMA ). (link)
  167. Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts. Alice P. Taylor and David M. Goldenberg. Molecular Cancer Therapeutics. 2007 6:524-531. (Product used TMA ). (link)
  168. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. Rosalyn D Blumenthal, et al. BMC Cancer. 2007 7:2. (Product used TMA BR1001, CO991 and LC801). (link)
  169. The Ubiquitin-Conjugating Enzyme E2-EPF Is Overexpressed in Primary Breast Cancer and Modulates Sensitivity to Topoisomerase II Inhibition. Donato Tedesco,et el. Neoplasia. 2007 9:601-613. (Product used TMA BR701). (link)
  170. Smad3 Is Overexpressed in Advanced Human Prostate Cancer and Necessary for Progressive Growth of Prostate Cancer Cells in Nude Mice. Shan Lu, Juwon Lee, Monica Revelo, Xiaohong Wang, Shan Lu and Zhongyun Dong. Clinical Cancer Research. 2007 13:5692-5702. (Product used TMA ). (link)
  171. Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma Cells. Youngsoo Kim, Joon Won Yoon, Xiaokun Xiao, Nicholas M.Dean, Brett P. Monia and Eric G. Marcusson . Cancer Research. 2007 67:3583-3593. (Product used TMA ). (link)
  172. Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human Neoplasia. Jennifer Y. Zhang, Amy E.Adams, Todd W. Ridky, Shiying Tao and Paul A. Khavari . Cancer Research. 2007 67:3827-3834. (Product used FFPE Sections ). (link)
  173. AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. Jing Zhang, et al. J.Clin.Invest. 2007 117:2962-2973. (Product used TMA BC19111). (link)
  174. A novel biomarker for the detection of esophageal adenocarcinoma. Zane T.Hammoud, et al. J Thorac Cardiovasc Surg. 2007 133:82-87. (Product used TMA ). (link)
  175. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Michael E. Hudson, Irina Pozdnyakova, et al. PANS. 2007 104 (44):17494-17499. (Product used TMA OR601). (link)
  176. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Zhenhua Miao, et al. PNAS. 2007 104(40):15735-15740. (Product used TMA ). (link)
  177. Overexpressed Raf-1 and phosphorylated cyclic adenosine 3-5-monophosphatate response element-binding protein are early markers for lung adenocarcinoma. Maria Cekanova, et al. Cancer. 2007 109(6):1164-1173. (Product used TMA LC1002). (link)
  178. Quantitative hypermethylation of NMDAR2B in human gastric cancer. Jun-Wei Liu, et al. International Journal of Cancer. 2007 121(9):1994-2000. (Product used TMA ). (link)
  179. Mammaglobin vs GCDFP-15: An Immunohistologic Validation Survey for Sensitivity and Specificity. Rohit Bhargava, et al. Am J Clin Pathol. 2007 127(1):103-113. (Product used TMA ). (link)
  180. Dickkopf-3 is expressed in a subset of adult human pancreatic beta cells. H.Hermman, et al. Histochemistry and Cell Biology. 2007 127(5):513-521. (Product used Tissue section ). (link)
  181. Haplotypes,Loss of Heterozygosity,and Expression Levels of Glycine N-Methyltransferase in Prostate Cancer. Yu-Chuen Huang, Cheng-Ming Lee, Marcelo Chen, Ming-Yi Chung, Yen-Hwa Chang, William Ji-Shian Huang, Donald Ming-Tak Ho, Chin-Chen Pan, Tony T. Wu, Stone Yang, Ming-Wei Lin, Jer-Tsong Hsieh and Yi-Ming Arthur Chen. Clinical Cancer Research. 2007 13(5):1412-1420. (Product used TMA ). (link)
  182. Association of Nuclear, Cytoplasmic Expression of Galectin-3 With beta-Catenin/Wnt-Pathway Activation in Thyroid Carcinoma. Paul M. Weinberger, MD, Bao-Ling Adam,PhD, Christine G. Gourin, MD, William H. Moretz III, MD, Roni J. Bollag, MD, PhD, Beverly Y. Wang, MD, Zhongmin Liu, PhD, Jeffrey R. Lee, MD, David J.Terris. Arch Otolaryngol Head Neck Surg. 2007 133(5):503-510. (Product used TMA TH802). (link)
  183. Expression of matrix metalloproteinases (MMP1, 2, 9, and 11) in metastatic lymph node tissue of breast cancer patients. A.Fink-Retter,et al. Journal of Clinical Oncology. 2007 25 (8S):21138. (Product used TMA BR1001). (link)
  184. Lobular Versus Ductal Breast Neoplasms: The Diagnostic Utility of P120 Catenin. Dabbs, David J., Bhargava, Rohit, Chivukula and Mamatha . American Journal of Surgical Pathology. 2007 31(3):427-437. (Product used TMA ). (link)
  185. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue (Abstract). Christoph Zenzmaier, Gerold Untergasser, Martin Hermann, Stephan Dirnhofer, Natalie Sampson and Peter Berge. The Prostate (Wiley-Liss, Inc., A Wiley Company)". 2007 68(5):540 - 547. (Product used TMA PR802). (link)
  186. The human papillomavirus type 16 E7 oncoprotein activates the Fanconi Anemia (FA) pathway and causes accelerated chromosomal instability in FA cells. Nicole Spardy, Anette Duensing, Domonique Charles, et al. J.Virol. 2007 81 (23):13265-13270. (Product used TMA CR801). (link)
  187. A Role for the G12 Family of Heterotrimeric G Proteins in Prostate Cancer Invasion*. Patrick Kelly, Laura N. Stemmle, John F .Madden, Timothy A. Fields, Yehia Daaka and Patrick J.Casey. THE JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 281(36): 26483-26490. (Product used TMA ). (link)
  188. The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Patrick Kelly, Benjamin J, Moeller, Juhi Juneja, Michelle A.Booden, Channing J.Der, Yehia Daaka, Mark W.Dewhirst, Timothy A.Fields and Patrick J.Casey. PNAS. 2006 21(103):8173-8178 . (Product used TMA ). (link)
  189. Vav3 Oncogene Is Overexpressed and Regulates Cell Growth and Androgen Receptor Activity in Human Prostate Cancer . Zhongyun Dong, Yin Liu, Shan Lu, Amy Wang, Kiwon Lee, Lu-Hai Wang, Monica Revelo and Shan Lu . Molecular Endocrinology. 2006 20 (10) :2315-2325. (Product used TMA ). (link)
  190. Tissue MicroArray (TMA) analysis of normal and persistent Chlamydophila pneumoniaeinfection. Nicole Borel, Sanghamitra Mukhopadhyay, Carmen Kaiser, Erin D Sullivan, Richard D Miller, Peter Timms, ames T Summersgill, Julio A Ramirez and Andreas Pospischil1 . BMC Infectious Diseases . 2006 6:152. (Product used TMA ). (link)
  191. Tissue Array Analysis of the Aberrant Expression of HLA Class I Molecules in Human Non-Small Cell Lung Cancer. SUZUKI HIROYUKI(Fukushima Medical Univ., School of Medicine, JPN) HIGUCHI MITSUNORI(Fukushima Medical Univ., School of Medicine, JPN) HASEGAWA TAKEO(Fukushima Medical Univ., School of Medicine, JPN) YONECHI ATSUSHI(Fukushima Medical Univ., School of Medicine, JPN) OSUGI JUN(Fukushima Medical Univ., School of Medicine, JPN) YAMADA FUMIHIKO(Fukushima Medical Univ., School of Medicine, JPN) HOSHINO MIKA(Fukushima Medical Univ., School of Medicine, JPN) SHIO YUTAKA(Fukushima Medical Univ., School of Medicine, JPN) FUJIU KOICHI(Fukushima Medical Univ., School of Medicine, JPN) GOTO MITSUKAZU(Fukushima Medical Univ., School of Medicine, JPN) . Japanese Journal of Cancer and Chemotherapy. 2006 33(12):1713-1716. (Product used TMA ). (link)
  192. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Philip L. Lorenzi, et al. Mol Cancer Ther. 2006 5:2613-2623. (Product used TMA OV2001). (link)
  193. Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Yaguang Xi, et al. Mol Cancer Ther . 2006 5:3078-3084. (Product used TMA ). (link)
  194. Molecular Profiling of ADAM12 in Human Bladder Cancer. Camilla Frohlich, et al. Clinical Cancer Research . 2006 12:7359-7368. (Product used TMA BC12011, BL801,. and BC12012). (link)
  195. CYP2A13 in Human Respiratory Tissues and Lung Cancers: An Immunohistochemical Study with A New Peptide-Specific Antibody. Liang-Ru Zhu, et all. Drug Metabolism and Disposition. 2006 34:1672-1676. (Product used Tissue section HuFPT111 and 131). (link)
  196. A role for the G12 family of heterotrimeric G-proteins in prostate cancer invasion. Patrick Kelly,Laura N.Stemmle,et al. J.Biol.Chem. 2006 36:26483-26490. (Product used TMA BR801). (link)
  197. Increased Levels of the FoxM1 Transcription Factor Accelerate Development and Progression of Prostate Carcinomas in both TRAMP and LADY Transgenic Mice. Tanya V.Kalin, et al. Cancer Research . 2006 66:1712-1720. (Product used TMA ). (link)
  198. The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer. Il-Man Kim,et al. Cancer Research . 2006 66:2153-2161. (Product used TMA LC1001). (link)
  199. Tyrosine Kinase Etk/BMX Is Up-regulated in Human Prostate Cancer and Its Overexpression Induces Prostate Intraepithelial Neoplasia in Mouse. Bojie Dai, et al. Cancer Research. 2006 66:8058-8064. (Product used TMA BC19111, PR801, and PR802). (link)
  200. The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis Patrick Kelly, et al. Patrick Kelly, Laura N. Stemmle, et al. PNAS. 2006 103(21):8173-8178. (Product used BR801 ). (link)
  201. A critical role for Ikappa B kinase alpha in the development of human and mouse squamous cell carcinomas. Bigang Liu, et all. Proc Natl Acad Sci USA. 2006 103(46):17202-17207. (Product used TMA SK801, SK802). (link)
  202. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Jongdae Lee, Christina C. N. Wu, Ki Jeong Lee, Tsung-Hsien Chuang, Kyoko Katakura, Yu-Tsueng Liu, Michael Chan, Rommel Tawatao, Michelle Chung, Carol Shen, Howard B. Cottam, Michael M. C. Lai, Eyal Raz and Dennis A.Carson . PNAS. 2006 103(6):1828-1833. (Product used TMA ). (link)
  203. Links between beta-catenin,NF-kappa B and squamous cell carcinoma in skin. Agnieszka Kobielak and Elaine Fuchs. PNAS. 2006 103(7):2322-2327. (Product used TMA ). (link)
  204. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism. Christian F Singer, Anneliese Fink-Retter, Daphne Gschwantler-Kaulich, Theresia Thalhammer, Gernot Hudelist, Ruth Mueller, Klaus Czerwenka and Ernst Kubista. Endocrine-Related Cancer. 2006 13(4):1101-1107. (Product used TMA ). (link)
  205. Isoform-specific regulation of UDP-glucuronosyltransferase (UGT)2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation. Sarah Chouinard, et al. Endocrinology. 2006 147(11):5431-5442. (Product used TMA ). (link)
  206. Vav3 Oncogene Is Overexpressed and Regulates Cell Growth and Androgen Receptor Activity in Human Prostate Cancer. Zhongyun Dong, et al. Molecular Endocrinology . 2006 20(10):2315-2325. (Product used TMA PR801, PR802). (link)
  207. WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Lynne Bingle, et al. Respiratory Research . 2006 7(1):61. (Product used TMA LC801). (link)
  208. The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer. Il-Man Kim, Timothy Ackerson, Sneha Ramakrishna, et al.. Cancer Res. 2006 66:2153-2161. (Product used TMA ). (link)
  209. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activityin human prostate cancer. Molecular Endocrinology. Zhongyun Dong, Yin Liu, Shan Lu, Amy Wang,et al. Molecular Endocrinology. 2006 :. (Product used TMA ). (link)
  210. Agnieszka Kobielak and Elaine Fuchs.Links between {alpha}-catenin, NF-{kappa}B and squamous cell carcinoma in skin. . PNAS. 2006 103:2322-2327. (Product used TMA ). (link)
  211. WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Lynne Bingle,Simon S Cross, Alec S High, William A Wallace, et al. Respiratory Research . 2006 :. (Product used TMA ). (link)
  212. Secretagogin is a Novel Marker for Neuroendocrine Differentiation. Karin Birkenkamp-Demtroder,et al. Neuroendocrinology. 2005 82:121-138. (Product used TMA EN801). (link)
  213. Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer . R. Simon, A. Nocito, T. Hübscher, C. Bucher, J. Torhorst, P. Schraml, L. Bubendorf, M. M. Mihatsch, H. Moch, G. Sauter (Institute of Pathology), A. Schtzau (Eye Clinic), University of Basel, Switzerland, K. Wilber, Vysis Inc., Downers Grove, IL, J. Kononen, Diomeda Life Sciences Inc and Rockville, MD. . JNCI Journal of the National Cancer Institute. 2001 93(15):1141-1146. (Product used TMA ). (link)

Tissue microarray technology:

  1. Holger Moch, Juha Kononen, Olli-P. Kallioniemi, and Guido Sauter, Tissue microarrays: what will they bring to molecular and anatomic pathology. Advances in Anatomic Pathology Vol.8, No.1,14-20, (2001).
  2. Ronald Simon, Jan Richter, Urs Wagner, et al., High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res. 61:4514-4519, (2001).
  3. Mark A. Rubin. Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate Cancer. J. Pathol. 195:80-86, (2001).
  4. Olli-P. Kallioniemi, Urs Wagner, Juha Kononen and Guido Sauter, Tissue microarray technology for high-throughput molecular profiling of cancer. Human Molecular Genetics Vol.10, No.7, 657-662, (2001).
  5. David L. Rimm, Robert L. Camp, Lori A.Charette, et al., Tissue microarray: a new technology for amplification of tissue resources. The Cancer Journal Vol.7, No.1, (2001).
  6. Lukas Bubendorf, Antonio Nocito, Holger Moch and Guido Sauter, Tissue microarray (TMA) technology: miniaturized pathology archives for high -Throughput in situ studies. J. Pathol. 195:72-79, (2001).
  7. Chad R. Englert, Galina V. Baibakov, and Michael R. Emmert-Buck, Cancer Res. 60:1526-1530, (2000).
  8. F. von Eggeling, H. Davies, L. Lomas, W. Fiedler, K. Junker, U. Claussen and G. Ernst, Tissue-specific microdissection coupled with proteinchip array technologies: applications in cancer research. Biotechniques Vol.29, No.5, 1066-1070, (2000).
  9. Olivier Braissant and Walter Wahli, A simplified in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica No.1, 10-16, (1998).
© 2003 - 2010 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal